From: Live bacterial vaccines – a review and identification of potential hazards
Vaccine strain | Attenuation | Foreign insert | Model | Ref. |
---|---|---|---|---|
Shigella flexneri | Δasd | pCMVβ | Guinea pig, in vitro | [80] |
Δasd | CS3 and LTB/STm | Mouse | [81] | |
Δrfb F | HIV-1 SF2Gag | Mouse | [17] | |
Δdap A Δdap B | β-gal, gene vaccine | In vitro | [16] | |
Δaro A Δisc A | gp120, gene vaccine | Mouse | [15] | |
Salmonella enterica | Δaro A | pCMVβ, pCMVact A and pCMVhly | In vitro, mouse | [82] |
Δaro A Δaro D | C. tetani TTFC | Mouse | [83] | |
Δaro A Δhtr A | TTFC | Mouse | [83] | |
Δaro A+others | GFP+cytokines | Mouse | [84] | |
Δcya Δcrp Δasd | SP10 cDNA | Mouse | [20] | |
Gal E + unspecified | H. pylori, ure AB | Human | [85] | |
Yersinia enterocolitica | pYV- | B. abortus, P39 | Mouse | [86] |
pYV- | Ova | Mouse | [87] | |
Listeria monocytogenes | Δact A | Leichmania major | Mouse | [88] |
Δact A | LCM virus | Mouse | [89] | |
Δdal Δdat | HIV-1 gag gene vaccine | Mouse | [90] | |
Δ2 | M. bovis gene vaccine | Mouse | [91] | |
Bordetella bronhiseptica | Δaro A | TTFC | Mouse | [92] |
Erysipelotrix rhusiopatie | Tn916- | M. hyopneumonie | Mouse, pig | [93] |
Mycobacterium bovis | unspecified | P. falciparum, CSP | Mouse | [94] |
Brucella abortus | Rough mutant (O-) | lac Z or HSP65 | Mouse | [95] |